Loading...

Julie Harris-Wai, PhD, MPH

TitleAssistant Professor
SchoolUCSF School of Nursing
DepartmentInstitute for Health Aging
Address3333 California Street
San Francisco CA 94118
Phone415-476-5362
vCardDownload vCard

    Collapse Biography 
    Collapse Education and Training
    University of Washington, SeattlePhD2008Public Health Genetics
    University of North Carolina, Chapel HillMPH2003Health Behavior and Health Education
    University of North Carolina at WilmingtonBS1998Biology, Marine Biology

    Collapse Overview 
    Collapse Overview
    Dr. Harris-Wai’s research focuses on examining the social and ethical factors influencing how and why genomic technologies are translated from the research setting into clinical care and the impact these technologies have on health disparities and underserved communities. The goal of her work is to identify methods for incorporating community and stakeholder perspectives into policy decision-making to improve the appropriate translation of research into clinical and public health programs. Dr. Harris-Wai is the Associate Director of the Kaiser Permanente/UCSF Center for Excellence in Research on Translational Genomics and Ethics (CT2G). She is currently working on an R21 from the Agency for Healthcare Research and Quality to use deliberative community engagement methods to inform policy decisions about the future of California’s Newborn Screening Program.

    Awarded Grants:
    1. Engaging Diverse Communities to Inform California’s Newborn Screening Policies, Principal Investigator; Agency for Healthcare Research and Quality (AHRQ), 2014-2016

    2. Center for Transdisciplinary ELSI Research in Translational Genomics (CT2G), Co-Investigator; National Human Genome Research Institute (NHGRI), 2013-2016

    3. Alameda County Network Project to Reduce Cancer Disparities, Co-Investigator; National Cancer Institute (NCI), 2010-2015


    Collapse Research 
    Collapse Research Activities and Funding
    Engaging Diverse Communities to Inform California's Newborn Screening Policies
    NIH R21HS023547Aug 1, 2014 - Jul 31, 2016
    Role: Principal Investigator

    Collapse ORNG Applications 
    Collapse Websites
    Collapse In The News
    Collapse Featured Videos

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Wolf SM, Amendola LM, Berg JS, Chung WK, Clayton EW, Green RC, Harris-Wai J, Henderson GE, Jarvik GP, Koenig BA, Lehmann LS, McGuire AL, O'Rourke P, Somkin C, Wilfond BS, Burke W. Navigating the research-clinical interface in genomic medicine: analysis from the CSER Consortium. Genet Med. 2017 Aug 31. PMID: 28858330.
      View in: PubMed
    2. Bowen DJ, Hay JL, Harris-Wai J, Meischke H, Burke W. All in the family? Communication of cancer survivors with their families. Fam Cancer. 2017 Apr 03. PMID: 28374161.
      View in: PubMed
    3. Joseph G, Chen F, Harris-Wai J, Puck JM, Young C, Koenig BA. Parental Views on Expanded Newborn Screening Using Whole-Genome Sequencing. Pediatrics. 2016 Jan; 137 Suppl 1:S36-46. PMID: 26729702; PMCID: PMC4939888.
    4. Lemke AA, Harris-Wai J. Stakeholder engagement in policy development: challenges and opportunities for human genomics. Genet Med. 2015 Dec; 17(12):949-57. PMID: 25764215; PMCID: PMC4567945.
    5. Bowen DJ, Burke W, Hay JL, Meischke H, Harris JN. Effects of web-based intervention on risk reduction behaviors in melanoma survivors. J Cancer Surviv. 2015 Jun; 9(2):279-86. PMID: 25425205; PMCID: PMC4442031.
    6. Harris JN, Liljestrand P, Alexander GL, Goddard KA, Kauffman T, Kolevska T, McCarty C, O'Neill S, Pawloski P, Rahm A, Williams A, Somkin CP. Oncologists' attitudes toward KRAS testing: a multisite study. Cancer Med. 2013 Dec; 2(6):881-8. PMID: 24403261; PMCID: PMC3892392.
    7. Cross DS, Rahm AK, Kauffman TL, Webster J, Le AQ, Spencer Feigelson H, Alexander G, Meier P, Onitilo AA, Pawloski PA, Williams AE, Honda S, Daida Y, McCarty CA, Goddard KA. Underutilization of Lynch syndrome screening in a multisite study of patients with colorectal cancer. Genet Med. 2013 Dec; 15(12):933-40. PMID: 23639899; PMCID: PMC3855589.
    8. Webster J, Kauffman TL, Feigelson HS, Pawloski PA, Onitilo AA, Potosky AL, Cross D, Meier PR, Mirabedi AS, Delate T, Daida Y, Williams AE, Alexander GL, McCarty CA, Honda S, Kushi LH, Goddard KA. KRAS testing and epidermal growth factor receptor inhibitor treatment for colorectal cancer in community settings. Cancer Epidemiol Biomarkers Prev. 2013 Jan; 22(1):91-101. PMID: 23155138; PMCID: PMC3567775.
    9. Bowen DJ, Hay JL, Mayer J, Kuniyuki A, Meischke H, Harris J, Asgari M, Shoveller J, Press N, Burke W. Predictors of recruited melanoma families into a behavioral intervention project. Contemp Clin Trials. 2012 Jan; 33(1):85-92. PMID: 22001361; PMCID: PMC4159354.
    10. Boehmer U, Harris J, Bowen DJ, Schroy PC. Surveillance after colorectal cancer diagnosis in a safety net hospital. J Health Care Poor Underserved. 2010 Nov; 21(4):1138-51. PMID: 21099067.
      View in: PubMed
    11. Harris JN, Hay J, Kuniyuki A, Asgari MM, Press N, Bowen DJ. Using a family systems approach to investigate cancer risk communication within melanoma families. Psychooncology. 2010 Oct; 19(10):1102-11. PMID: 20119933; PMCID: PMC2888971.
    12. Bowen DJ, Harris J, Jorgensen CM, Myers MF, Kuniyuki A. Socioeconomic influences on the effects of a genetic testing direct-to-consumer marketing campaign. Public Health Genomics. 2010; 13(3):131-42. PMID: 19641293.
      View in: PubMed
    13. Harris JN, Bowen DJ, Kuniyuki A, McIntosh L, FitzGerald LM, Ostrander EA, Stanford JL. Interest in genetic testing among affected men from hereditary prostate cancer families and their unaffected male relatives. Genet Med. 2009 May; 11(5):344-55. PMID: 19346959; PMCID: PMC2683189.
    14. Hay J, Harris JN, Waters EA, Clayton MF, Ellington L, Abernethy AD, Prayor-Patterson H. Personal communication in primary and secondary cancer prevention: evolving discussions, emerging challenges. J Health Commun. 2009; 14 Suppl 1:18-29. PMID: 19449265.
      View in: PubMed
    15. Harris J, Bowen DJ, Badr H, Hannon P, Hay J, Regan Sterba K. Family communication during the cancer experience. J Health Commun. 2009; 14 Suppl 1:76-84. PMID: 19449271.
      View in: PubMed
    16. James RD, Yu JH, Henrikson NB, Bowen DJ, Fullerton SM. Strategies and stakeholders: minority recruitment in cancer genetics research. Community Genet. 2008; 11(4):241-9. PMID: 18417972.
      View in: PubMed
    17. Veenstra DL, Harris J, Gibson RL, Rosenfeld M, Burke W, Watts C. Pharmacogenomic testing to prevent aminoglycoside-induced hearing loss in cystic fibrosis patients: potential impact on clinical, patient, and economic outcomes. Genet Med. 2007 Oct; 9(10):695-704. PMID: 18073583.
      View in: PubMed
    18. Henrikson NB, Harris JN, Bowen DJ. Predictors of self-referral into a cancer genetics registry. Cancer Epidemiol Biomarkers Prev. 2007 Jul; 16(7):1387-92. PMID: 17627003.
      View in: PubMed
    Julie's Networks
    Concepts
    Derived automatically from this person's publications.
    _
    Co-Authors
    People in Profiles who have published with this person.
    _
    Related Authors
    People who share related concepts with this person.
    _
    Back to TOP